Article Text

PDF
Evidence for the outcomes and impact of clinical pharmacy: context of UK hospital pharmacy practice
  1. Raliat Onatade1,2,
  2. Sandra Appiah2,
  3. Martin Stephens3,
  4. Hemda Garelick2
  1. 1Pharmacy Department, Institute of Pharmaceutical Science, King’s College London, London, UK
  2. 2Department of Natural Sciences, Faculty of Science and Technology, Middlesex University, London, UK
  3. 3Pharmacy, University of Portsmouth, Portsmouth, UK
  1. Correspondence to Raliat Onatade, Pharmacy Department, Barts Health NHS Trust, London E1 2ES, UK; raliat.onatade{at}nhs.net

Abstract

Objectives The role of clinical pharmacists in hospitals has evolved and continues to expand. In the UK, outside of a few national policy drivers, there are no agreed priorities, measures or defined outcomes for hospital clinical pharmacy (CP). This paper aims to (1) highlight the need to identify and prioritise specific CP roles, responsibilities and practices that will bring the greatest benefit to patients and health systems and (2) describe systematic weaknesses in current research methodologies for evaluating CP services and propose a different approach.

Method Published reviews of CP services are discussed using the Economic, Clinical and Humanistic Outcomes framework. Recurring themes regarding study methodologies, measurements and outcomes are used to highlight current weaknesses in studies evaluating CP.

Results Published studies aiming to demonstrate the economic, clinical or humanistic outcomes of CP often suffer from poor research design and inconsistencies in interventions, measurements and outcomes. This has caused difficulties in drawing meaningful conclusions regarding CP’s definitive contribution to patient outcomes.

Conclusion There is a need for more research work in National Health Service (NHS) hospitals, employing a different paradigm to address some of the weaknesses of existing research on CP practice. We propose a mixed-methods approach, including qualitative research designs, and with emphasis on cost-consequence analyses for economic evaluations. This approach will provide more meaningful data to inform policy and demonstrate the contribution of hospital CP activities to patient care and the NHS.

  • clinical pharmacy
  • economic outcomes
  • hospital
  • United Kingdom
  • clinical outcomes
  • humanistic outcomes
  • research methodologies
View Full Text

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.